Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
4.680
-0.050 (-1.06%)
Nov 3, 2026, 2:45 PM EST - Market open
Savara Market Cap
Savara has a market cap or net worth of $1.19 billion as of November 3, 2026. It is the 8,996th most valuable company in the world and the 2,112th biggest in the United States. Its market cap has increased by 65.81% in one year.
Market Cap
1.19B
Enterprise Value
1.04B
1-Year Change
65.81%
Global Rank
Country Rank
#2,112 United States
Category
ChartMarket Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $1.19B, an increase of 796.28%. That is a compound annual growth rate of 25.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 971.80M | -20.79% |
| Dec 31, 2025 | 1.23B | 132.85% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 1.33B |
| Damora Therapeutics | 1.33B |
| Kardigan | 1.32B |
| LB Pharmaceuticals | 1.28B |
| Ascentage Pharma Group International | 1.27B |
| Syndax Pharmaceuticals | 1.22B |
| Vor Biopharma | 1.21B |
| Alpha Tau Medical | 1.21B |